IMGN - ImmunoGen, Inc.
Close
31.23
0 0%
Share volume: 0
Last Updated: Fri 09 Feb 2024 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$31.23
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-06 | 2022-08-01 | 2022-11-04 | 2023-03-01 | 2023-04-28 | 2023-07-31 | 2023-11-02 | |
| Assets | ||||||||
| Total Assets | 481.709 M | 422.295 M | 358.799 M | 348.936 M | 288.345 M | 714.327 M | 822.101 M | |
| Current Assets | 456.718 M | 393.924 M | 330.416 M | 320.317 M | 243.864 M | 669.273 M | 766.900 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 16.196 M | 614.000 K | 3.233 M | 5.495 M | |
| Other Current Assets | 11.807 M | 14.099 M | 16.714 M | 11.005 M | 10.955 M | 14.089 M | 18.712 M | |
| Short Term Investments | 11.807 M | 14.099 M | 16.714 M | 11.005 M | 10.955 M | 14.089 M | 18.712 M | |
| Total Receivables | 7.250 M | 5.951 M | 4.191 M | 17.978 M | 31.046 M | 79.964 M | 137.158 M | |
| Current Cash | 437.661 M | 373.874 M | 309.511 M | 275.138 M | 201.249 M | 571.987 M | 605.535 M | |
| Total Non-current Assets | 24.991 M | 28.371 M | 28.383 M | 28.619 M | 44.481 M | 45.054 M | 55.201 M | |
| Property Plant Equipment | 4.431 M | 4.334 M | 4.474 M | 4.377 M | 4.067 M | 3.776 M | 4.431 M | |
| Other Assets | 8.672 M | 12.676 M | 13.100 M | 14.011 M | 30.787 M | 32.281 M | 42.432 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 481.709 M | 422.295 M | 358.799 M | 348.936 M | 288.345 M | 714.327 M | 822.101 M | |
| Total liabilities | 175.241 M | 172.464 M | 180.792 M | 193.110 M | 166.427 M | 223.485 M | 260.505 M | |
| Total current liabilities | 84.118 M | 87.071 M | 103.642 M | 121.858 M | 101.629 M | 93.702 M | 134.660 M | |
| Accounts Payable | 16.060 M | 17.245 M | 20.178 M | 45.353 M | 32.260 M | 18.441 M | 24.853 M | |
| Other liabilities | 76.860 M | 72.139 M | 64.933 M | 60.104 M | 54.749 M | 48.906 M | 45.973 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 71.957 M | 72.113 M | |
| Other liabilities | 76.860 M | 72.139 M | 64.933 M | 60.104 M | 54.749 M | 48.906 M | 45.973 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 306.468 M | 249.831 M | 178.007 M | 155.826 M | 121.918 M | 490.842 M | 561.596 M | |
| Common stock | 253.263 M | 253.336 M | 253.511 M | 254.414 M | 258.848 M | 263.446 M | 273.341 M | |
| Retained earnings | -1.495 B | -1.557 B | -1.635 B | -1.694 B | -1.735 B | -1.739 B | -1.709 B |